Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,781,354 papers from all fields of science
Search
Sign In
Create Free Account
COPP-ABV Regimen
Known as:
COPP-ABV
, Cytoxan-Oncovin-Procarbazine-Prednisone/Adriamycin-Bleomycin-Vinblastine Regimen
A regimen consisting of cyclophosphamide, vincristine, prednisone and procarbazine (COPP) alternating with doxorubicin, bleomycin and vinblastine…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Bleomycin
Cyclophosphamide
Doxorubicin
Prednisone
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
A novel endogenous badnavirus exists in Alhagi sparsifolia
Yong-chao Li
,
Jian-guo Shen
,
Guoli Zhao
,
Q. Yao
,
Wei-min Li
Journal of Zhejiang University SCIENCE B
2018
Corpus ID: 4613513
We report the recovery of a 7068-nt viral sequence from the “viral fossils” embedded in the genome of Alhagi sparsifolia, a…
Expand
2018
2018
PENGARUH LATIHAN PLYOMETRIC STANDING JUMP TERHADAP TINGGI LONCATAN PEMAIN BOLAVOLI PUTRA UABV UNIVERSITAS NEGERI MALANG
achmad muzayyin dwi fernanda
,
M. Yunus
,
Saichudin Saichudin
2018
Corpus ID: 127160488
Abstract UABV Volleyball Players State University of Malang focus more on the exercises and no physical improvement exercises…
Expand
2017
2017
Fast deduplication data transmission scheme on a big data real-time platform
Sheng-Tzong Cheng
,
Jian Ting Chen
,
Yin Chun Chen
International Symposium on Business Modeling and…
2017
Corpus ID: 53467382
: In this information era, it is difficult to exploit and compute high-amount data efficiently. Today, it is inadequate to use…
Expand
2013
2013
The long lineage of the Carol cow family produces top ABV sire, CANBEE
A. Chamberlain
2013
Corpus ID: 133284785
Australian Holsteins and cow families are claiming their space in global Holstein circles. Anne Chamberlain reports.
2005
2005
O uso do permanganato de potássio no controle de trihalometanos e compostos causadores de gosto e odor
J. D. Santos
,
Cláudia Regina Mota dos Santos
,
K. R. D. Oliveira
,
Orlando Ramos do Nascimento
,
Célio de Souza Mattos
2005
Corpus ID: 192497950
Jose Roberto Kachel dos Santos Engenheiro Civil pela Faculdade de Engenharia da UMC. Engenheiro Sanitarista pela Faculdade de…
Expand
2003
2003
Randomized C omparison o f A BVD a nd M OPP/ABV H ybrid f or the T reatment o f A dvanced H odgkin's D isease: R eport o f a n Intergroup T rial
D. Duggan
,
G. Petroni
,
+5 authors
B. Peterson
2003
Corpus ID: 58368885
Purpose: In a series of trials, doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) and mechlorethamine, vincristine…
Expand
2002
2002
Tratamiento de la enfermedad de hodgkin: esquema MOPP/ABV toxicidad (2a neoplasia): seguimiento durante 10 años
G. Acquatella
,
R. Somoza
,
+9 authors
Oswaldo Travieso
2002
Corpus ID: 160232524
1999
1999
ChlVPP/ABV-VP16 hybrid regimen for advanced Hodgkin's disease: a study in 36 patients.
P. Saletti
,
E. Zucca
,
M. Guéneau
,
F. Peccatori
,
F. Cavalli
,
G. Martinelli
Leukemia and Lymphoma
1999
Corpus ID: 8630950
Prolonged remission can now be induced in the majority of patients with advanced Hodgkin's disease (HD) by the use of non-cross…
Expand
1999
1999
17 Wyniki leczenia ziarnicy złośliwej w stopniu klinicznym od I do IV w materiale Regionalnego Centrum Onkologii w Bydgoszczy
E. Pietrusińska
,
A. Lebioda
,
E. Ziółkowska
,
W. Windorbska
1999
Corpus ID: 72228876
1997
1997
[Combination chemotherapy with total or subtotal lymphatic irradiation in the treatment of lymphogranulomatosis, stage IIIA or IIIB (based on five- and ten-year results)].
S. Kanaev
,
M. Gershanovich
,
A. Malinin
Voprosi onkologii
1997
Corpus ID: 39487692
High rates of overall and recurrence-free 5- and 10-year survival were recorded in 561 patients with Hodgkin's disease (stage…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE